Synthesis and structure–activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity
| Autor: | Vigilio Ballabeni, Marco Mor, Giovanni Morini, Fabrizio Bordi, Pier Vincenzo Plazzi, Simona Bertoni, Francesca Saccani, Mirko Rivara, Silvia Rivara, Lisa Flammini, Elisabetta Barocelli, Mara Comini |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Stereochemistry
Guinea Pigs Clinical Biochemistry Histamine Antagonists Pharmaceutical Science Biochemistry Chemical synthesis Structure-Activity Relationship chemistry.chemical_compound Histamine receptor Piperidines Drug Discovery Animals Humans Receptors Histamine H3 Structure–activity relationship Receptor Molecular Biology Cells Cultured Cholinesterase biology Chemistry Biphenyl Compounds Organic Chemistry Acetylcholinesterase Rats biology.protein Molecular Medicine Cholinesterase Inhibitors Piperidine Histamine H3 receptor |
| Zdroj: | Bioorganic & Medicinal Chemistry. 16:9911-9924 |
| ISSN: | 0968-0896 |
| DOI: | 10.1016/j.bmc.2008.10.029 |
| Popis: | The combination of antagonism at histamine H 3 receptors and inhibition of acetylcholinesterase has been recently proposed as an approach to devise putative new therapeutic agents for cognitive diseases. The 4,4′-biphenyl fragment has been reported by us as a rigid scaffold leading to potent and selective non-imidazole H 3 -antagonists. Starting from these premises, the current work presents an expanded series of histamine H 3 receptor antagonists, characterized by a central 4,4′-biphenyl scaffold, where the structure–activity profile of both mono-basic and di-basic compounds is further explored and their ability to inhibit rat brain cholinesterase activity is determined. The steric properties and basicity of the terminal groups were modulated in symmetrical compounds, carrying identical substituents, and in asymmetrical compounds, having a piperidine ring at one end and different groups at the other. The length of the linker connecting the biphenyl scaffold to the terminal groups was also modulated. Binding studies at rat and human H 3 receptors evidenced the highest binding affinities for di-basic compounds, in the order of nM concentrations, and that the steric requirements for the two terminal groups are different. Many potent compounds showed good selectivity profiles over the other histamine receptors. Interestingly, some derivatives displayed a moderate ability to inhibit rat brain cholinesterase, for example compound 12 (1-[2-(4′-piperidinomethyl-biphenyl-4-yl)ethyl]piperidine) has a pIC 50 = 5.96 for cholinesterase inhibition and high H 3 receptor binding affinity and antagonist potency (p K i = 8.70; p K B = 9.28). These compounds can be considered as rigid analogs of a recently reported class of dual-acting compounds and as a promising starting point for the design of new H 3 -antagonists with anti-cholinesterase activity. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect